BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22139066)

  • 1. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
    Avery S; Voss MH; Gonzales AM; Lubin M; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Hedvat CV; Stevens CE; Barker JN
    Bone Marrow Transplant; 2012 Aug; 47(8):1056-60. PubMed ID: 22139066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
    Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
    Moscardó F; Sanz J; Senent L; Cantero S; de la Rubia J; Montesinos P; Planelles D; Lorenzo I; Cervera J; Palau J; Sanz MA; Sanz GF
    Haematologica; 2009 Jun; 94(6):827-32. PubMed ID: 19483157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.
    Dahi PB; Barone J; Devlin SM; Byam C; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Hsu SH; Barker JN
    Biol Blood Marrow Transplant; 2014 May; 20(5):735-9. PubMed ID: 24462980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.
    Somers JA; Braakman E; van der Holt B; Petersen EJ; Marijt EW; Huisman C; Sintnicolaas K; Oudshoorn M; Groenendijk-Sijnke ME; Brand A; Cornelissen JJ
    Haematologica; 2014 Nov; 99(11):1753-61. PubMed ID: 25107890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.
    Childs R; Clave E; Contentin N; Jayasekera D; Hensel N; Leitman S; Read EJ; Carter C; Bahceci E; Young NS; Barrett AJ
    Blood; 1999 Nov; 94(9):3234-41. PubMed ID: 10556212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.
    Dahi PB; Ponce DM; Devlin S; Evans KL; Lubin MN; Gonzales AM; Tonon J; Meagher R; Giralt S; Kernan NA; Scaradavou A; Barker JN
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):490-4. PubMed ID: 24361912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan.
    Kai S; Wake A; Okada M; Kurata M; Atsuta Y; Ishikawa J; Nakamae H; Aotsuka N; Kasai M; Misawa M; Taniguchi S; Kato S
    Biol Blood Marrow Transplant; 2013 May; 19(5):812-9. PubMed ID: 23416856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.
    Sugita J; Tanaka J; Hashimoto A; Shiratori S; Yasumoto A; Wakasa K; Kikuchi M; Shigematsu A; Miura Y; Tsutsumi Y; Kondo T; Asaka M; Imamura M
    Ann Hematol; 2008 Dec; 87(12):1003-8. PubMed ID: 18636260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation.
    Pichler H; Witt V; Winter E; Boztug H; Glogova E; Pötschger U; Matthes-Martin S; Fritsch G
    Biol Blood Marrow Transplant; 2014 May; 20(5):676-83. PubMed ID: 24492145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
    Misawa M; Kai S; Okada M; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Fujimori Y; Ogawa H; Hara H
    Int J Hematol; 2006 Jan; 83(1):74-9. PubMed ID: 16443557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
    Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN
    Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early phase mixed chimerism in bone marrow does not affect long-term outcomes of myeloablative single-unit cord blood transplantation for adult patients with hematological malignancies.
    Konuma T; Kato S; Oiwa-Monna M; Ishii H; Tojo A; Takahashi S
    Leuk Lymphoma; 2016 Dec; 57(12):2848-2854. PubMed ID: 27124418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.
    Patel KJ; Rice RD; Hawke R; Abboud M; Heller G; Scaradavou A; Young JW; Barker JN
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):435-40. PubMed ID: 19857590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable mixed donor-donor chimerism after double cord blood transplantation.
    Berglund S; Okas M; Gertow J; Uhlin M; Mattsson J
    Int J Hematol; 2009 Nov; 90(4):526-531. PubMed ID: 19697099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.
    Purtill D; Smith K; Devlin S; Meagher R; Tonon J; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Stevens CE; Barker JN
    Blood; 2014 Nov; 124(19):2905-12. PubMed ID: 25185264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.